Diabetes, Parkinson's disease
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Diabetes Drug Linked to 20% Lower Risk of Dementia, Parkinson's
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | Neuroscience
Study: Diabetes Drug May Cut Risk of Alzheimer’s and Parkinson’s by 20%
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, according to a large study. Results showed a 20% to 30% lower risk for these conditions,
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
SGLT2 inhibitors reduce dementia, Parkinson’s disease risk: study
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk for dementia and Parkinson’s disease, a new study finds.
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
New study to investigate non-invasive treatment for dementia and Parkinson’s
A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...
Dementia and Parkinson's 'cure' to be investigated in new first-of-its-kind research
A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...
New scientific study looks at Alzheimer's, dementia and Parkinson's 'cure'
The project, by scientists at Nottingham Trent University, will look at whether treatment can be delivered to the brain via ...
Types of Alzheimer's disease and how lifestyle choices and regular exercise can help reduce risk
Around 55 million people globally are affected by dementia, with Alzheimer's disease responsible for 70% of these cases. The ...